National Cancer Institute; Notice of Meeting, 73852 [07-6186]
Download as PDF
<![CDATA[
73852
Federal Register / Vol. 72, No. 248 / Friday, December 28, 2007 / Notices
and management of information
supporting the process for the review of
human drug applications throughout the
product life cycle. As part of this
process, FDA will develop and
periodically update a 5-year IT plan and
will solicit and consider comments from
the public on the draft IT plan. At the
end of the comment period, FDA will
review the comments, update the IT
plan, and publish the final version no
later than May 30, 2008.
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(6), Title 5 U.S.C., as
amended to discuss personnel matters,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that in January 2008, the
FDA Web site is expected to transition
to the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. After the transition
date, electronic submissions will be
accepted by FDA through the FDMS
only. When the exact date of the
transition to FDMS is known, FDA will
publish a Federal Register notice
announcing that date.
Name of Committee: NIH Advisory Board
for Clinical Research
Date: January 28, 2008.
Open: 10 a.m. to 1:15 p.m.
Agenda: To review the 2008 Clinical
Center Operating Plan and provide updates
on selected organizational initiatives.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Closed: 1:15 p.m. to 2 p.m.
Agenda: To review and evaluate personnel
matters.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Contact Person: Maureen E Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, 301–496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
III. Electronic Access
Persons with access to the Internet
may obtain the document at https://
www.fda.gov/ohrms/dockets/
default.htm.
Dated: December 20, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–25310 Filed 12–27–07; 8:45 am]
BILLING CODE 4160–01–S
Dated: December 18, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6208 Filed 12–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Clinical Center; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
VerDate Aug<31>2005
22:27 Dec 27, 2007
Jkt 214001
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public as indicated below, with
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be closed to the public in
accordance with the provisions set forth
in section 552(c)(9)(B), Title 5 U.S.C., as
amended, because the premature
disclosure of information and the
discussions would likely to significantly
frustrate implementation of
recommendations.
Name of Committee: President’s Cancer
Panel.
Date: January 28, 2008.
Open: January 28, 2008, 7:30 a.m.–3:30
p.m.
Agenda: Strategies for Maximizing the
Nation’s Investment in Cancer.
Place: Chateau Sonesta Hotel, 800 Iberville
St., New Orleans, LA 70112.
Closed: January 28, 2008, 4 p.m.–6 p.m.
Agenda: Strategies for Maximizing the
Nation’s Investment in Cancer and discuss
potential topics for the 2008/2009 series.
Place: Chateau Sonesta Hotel, 800 Iberville
St., New Orleans, LA 70112.
Contact Person: Abby Sandler, PhD,
Executive Secretary, National Cancer
Institute, National Institutes of Health,
Building 6116, Room 212, 6116 Executive
Boulevard, Bethesda, MD 20892, 301–451–
9399.
Any interested person may file written
comments with the committee by forwarding
the comments to the Contact Person listed on
this notice. The comments should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 19, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6186 Filed 12–27–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 72, Number 248 (Friday, December 28, 2007)]
[Notices]
[Page 73852]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the President's Cancer Panel.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The meeting will be closed to
the public in accordance with the provisions set forth in section
552(c)(9)(B), Title 5 U.S.C., as amended, because the premature
disclosure of information and the discussions would likely to
significantly frustrate implementation of recommendations.
Name of Committee: President's Cancer Panel.
Date: January 28, 2008.
Open: January 28, 2008, 7:30 a.m.-3:30 p.m.
Agenda: Strategies for Maximizing the Nation's Investment in
Cancer.
Place: Chateau Sonesta Hotel, 800 Iberville St., New Orleans, LA
70112.
Closed: January 28, 2008, 4 p.m.-6 p.m.
Agenda: Strategies for Maximizing the Nation's Investment in
Cancer and discuss potential topics for the 2008/2009 series.
Place: Chateau Sonesta Hotel, 800 Iberville St., New Orleans, LA
70112.
Contact Person: Abby Sandler, PhD, Executive Secretary, National
Cancer Institute, National Institutes of Health, Building 6116, Room
212, 6116 Executive Boulevard, Bethesda, MD 20892, 301-451-9399.
Any interested person may file written comments with the
committee by forwarding the comments to the Contact Person listed on
this notice. The comments should include the name, address,
telephone number and, when applicable, the business or professional
affiliation of the interested person. Information is also available
on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/
pcp/pcp.htm, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 19, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-6186 Filed 12-27-07; 8:45 am]
BILLING CODE 4140-01-M
